LNG-IUS治疗子宫腺肌症的安全性及可行性分析

Analysis of Safety and Feasibility of LNG-IUS in the Treatment of Adenomyosis

目的探讨左炔诺孕酮宫内缓释系统(LNG-IUS)在治疗子宫腺肌症的安全性和可行性。方法回顾性分析100例子宫腺肌症患者的临床资料。结果放置3个月后,患者的痛经现象得到明显的改善,月经量减少(P<0.05);子宫体积12个月内无明显变化(P<0.05),患者的不良反应较少且症状较轻。结论左炔诺孕酮宫内缓释系统(LNGIUS)治疗子宫腺肌症的安全性和可行性都较高。

Objective To explore the safety and feasibility of LNG-IUS in the treatment of adenomyosis.Methods A retrospective analysis was performed on clinical data of 100 patients with adenomyosis. Results Placed after 3 months, the phenomenon of dysmenorrhea patients improved obviously, and menstrual reduction （P〈0.05）; there was no significant change in uterine volume within 12 months （P〉0.05）, patients with less adverse reactions and mild symptoms.Conclusion Levonorgestrel releasing intrauterine system （LNG-IUS） safety and feasibility for the treatment of adenomyosis are higher.